Manufacturer’s plans for equitable access to twice-yearly PrEP under fire
HIV testing requirements must be simplified for injectable PrEP to have a future
Injectable PrEP use leads to zero new HIV infections among gay, trans and non-binary Brazilians
Once-yearly PrEP moves closer: experimental lenacapavir formulations show promise
Six-monthly injectable PrEP is 89% more effective than oral PrEP in gay and bisexual men and trans people
No HIV infections seen in groundbreaking trial of twice-yearly injectable PrEP
TAF may be effective as once-weekly PrEP
Why is the roll-out of injectable PrEP taking so long?
Top 5 stories on injectable HIV treatment and PrEP from CROI 2024
